CCN1 and ovarian carcinoma: Consistent with these clinical data, our experimental results showed that knockdown of the endogenous CCN1 and CCN2 significantly decreased the cell proliferation in EOC cells, indicating that CCN1 and CCN2 might play a pivotal role in the progression and outcome of ovarian cancers.